I'd make the distinction, as you do, I think, in your question between manufacturing and development. Manufacturing, as we've seen with the Sanofi plant that will open in the coming months, is relatively easier to ramp up, and I'd make that point, by the way, about developing countries as well. Jesse is right: It is condescending to simply say we shouldn't open up technology to other countries because they wouldn't know what to do with it. That may be the case in many countries, but certainly not in the emerging countries, many of which are ahead of Canada in innovation indexes and other such measures.
On development, I think that's a fair point. I'd really want to know who owns the IP, because that's where the value is. If it's a question of having heavy subsidies for a foreign firm to locate in Canada, but the IP still resides elsewhere and there are just a few well-paid scientists and lobbyists in Canada, that's not the end game.
On the question of putting all our eggs in one basket, as Mark just said, we'd still be waiting for a vaccine, but these are not either/or propositions. Canada can have homegrown innovation sectors and still engage with the rest of the world and make deals. In fact, our hand in making deals would be stronger if we had homegrown innovation capacity, so let's not create false dichotomies where none exist.